vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and Valens Semiconductor Ltd. (VLN). Click either name above to swap in a different company.
Apyx Medical Corp is the larger business by last-quarter revenue ($19.2M vs $17.3M, roughly 1.1× Valens Semiconductor Ltd.). Apyx Medical Corp runs the higher net margin — -6.8% vs -42.2%, a 35.5% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 8.1%). Apyx Medical Corp produced more free cash flow last quarter ($-2.8M vs $-4.9M).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
Valens Semiconductor (Valens) is an Israeli fabless manufacturing company providing semiconductors for the automotive and audio-video industries. Valens provides semiconductor products for the distribution of uncompressed ultra-high-definition (UHD) multimedia content and in-vehicle connectivity applications. The company is a member of the MIPI Alliance and developed the first-to-market chipset that is compliant with the MIPI A-PHY standard. Valens invented the technology behind the HDBaseT s...
APYX vs VLN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $17.3M |
| Net Profit | $-1.3M | $-7.3M |
| Gross Margin | 62.6% | 63.0% |
| Operating Margin | 0.1% | -46.4% |
| Net Margin | -6.8% | -42.2% |
| Revenue YoY | 34.7% | 8.1% |
| Net Profit YoY | 71.9% | 29.3% |
| EPS (diluted) | — | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | — | ||
| Q3 25 | $12.9M | $17.3M | ||
| Q2 25 | $11.4M | $17.1M | ||
| Q1 25 | $9.4M | $16.8M | ||
| Q4 24 | $14.2M | — | ||
| Q3 24 | $11.5M | $16.0M | ||
| Q2 24 | $12.1M | $13.6M | ||
| Q1 24 | $10.2M | — |
| Q4 25 | $-1.3M | — | ||
| Q3 25 | $-2.0M | $-7.3M | ||
| Q2 25 | $-3.8M | $-7.2M | ||
| Q1 25 | $-4.2M | $-8.3M | ||
| Q4 24 | $-4.6M | — | ||
| Q3 24 | $-4.7M | $-10.4M | ||
| Q2 24 | $-6.6M | $-8.9M | ||
| Q1 24 | $-7.6M | — |
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | 63.0% | ||
| Q2 25 | 62.3% | 63.5% | ||
| Q1 25 | 60.1% | 62.9% | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | 56.4% | ||
| Q2 24 | 61.7% | 61.4% | ||
| Q1 24 | 58.1% | — |
| Q4 25 | 0.1% | — | ||
| Q3 25 | -6.5% | -46.4% | ||
| Q2 25 | -22.6% | -43.3% | ||
| Q1 25 | -32.4% | -56.2% | ||
| Q4 24 | -21.4% | — | ||
| Q3 24 | -31.6% | -76.3% | ||
| Q2 24 | -45.7% | -69.2% | ||
| Q1 24 | -64.6% | — |
| Q4 25 | -6.8% | — | ||
| Q3 25 | -15.4% | -42.2% | ||
| Q2 25 | -33.2% | -42.1% | ||
| Q1 25 | -44.0% | -49.4% | ||
| Q4 24 | -32.5% | — | ||
| Q3 24 | -40.9% | -64.6% | ||
| Q2 24 | -54.0% | -65.2% | ||
| Q1 24 | -74.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.07 | ||
| Q2 25 | — | $-0.07 | ||
| Q1 25 | — | $-0.08 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.10 | ||
| Q2 24 | $-0.19 | $-0.08 | ||
| Q1 24 | $-0.22 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $93.5M |
| Total DebtLower is stronger | $37.5M | — |
| Stockholders' EquityBook value | $14.5M | $108.8M |
| Total Assets | $66.8M | $136.7M |
| Debt / EquityLower = less leverage | 2.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | — | ||
| Q3 25 | $25.1M | $93.5M | ||
| Q2 25 | $29.3M | $102.7M | ||
| Q1 25 | $31.0M | $112.5M | ||
| Q4 24 | $31.7M | — | ||
| Q3 24 | $28.0M | $133.1M | ||
| Q2 24 | $32.7M | $105.9M | ||
| Q1 24 | $37.3M | — |
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.5M | — | ||
| Q3 25 | $5.8M | $108.8M | ||
| Q2 25 | $7.3M | $116.5M | ||
| Q1 25 | $10.5M | $128.6M | ||
| Q4 24 | $14.2M | — | ||
| Q3 24 | $11.0M | $147.0M | ||
| Q2 24 | $14.7M | $153.5M | ||
| Q1 24 | $20.3M | — |
| Q4 25 | $66.8M | — | ||
| Q3 25 | $57.4M | $136.7M | ||
| Q2 25 | $58.2M | $144.8M | ||
| Q1 25 | $60.2M | $154.6M | ||
| Q4 24 | $64.8M | — | ||
| Q3 24 | $60.7M | $171.9M | ||
| Q2 24 | $65.4M | $175.8M | ||
| Q1 24 | $70.7M | — |
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $-4.7M |
| Free Cash FlowOCF − Capex | $-2.8M | $-4.9M |
| FCF MarginFCF / Revenue | -14.6% | -28.5% |
| Capex IntensityCapex / Revenue | 1.4% | 1.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $-11.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | — | ||
| Q3 25 | $-3.5M | $-4.7M | ||
| Q2 25 | $-1.2M | $-211.0K | ||
| Q1 25 | $-702.0K | $-7.6M | ||
| Q4 24 | $-2.9M | — | ||
| Q3 24 | $-4.4M | $3.0M | ||
| Q2 24 | $-4.3M | $-225.0K | ||
| Q1 24 | $-6.3M | — |
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-4.1M | $-4.9M | ||
| Q2 25 | $-1.5M | $-330.0K | ||
| Q1 25 | $-757.0K | $-8.0M | ||
| Q4 24 | $-3.2M | — | ||
| Q3 24 | $-4.6M | $2.2M | ||
| Q2 24 | $-4.6M | $-460.0K | ||
| Q1 24 | $-6.4M | — |
| Q4 25 | -14.6% | — | ||
| Q3 25 | -31.5% | -28.5% | ||
| Q2 25 | -13.2% | -1.9% | ||
| Q1 25 | -8.0% | -47.3% | ||
| Q4 24 | -22.4% | — | ||
| Q3 24 | -40.0% | 14.0% | ||
| Q2 24 | -38.0% | -3.4% | ||
| Q1 24 | -62.2% | — |
| Q4 25 | 1.4% | — | ||
| Q3 25 | 4.0% | 1.6% | ||
| Q2 25 | 2.3% | 0.7% | ||
| Q1 25 | 0.6% | 2.1% | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | 1.3% | 4.5% | ||
| Q2 24 | 2.4% | 1.7% | ||
| Q1 24 | 0.3% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
